A citation-based method for searching scientific literature

Guojuan Jiang, Wanglong Deng, Yang Liu, Chengde Wang. Mol Med Rep 2020
Times Cited: 12







List of co-cited articles
53 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Bromodomains: Structure, function and pharmacology of inhibition.
Elena Ferri, Carlo Petosa, Charles E McKenna. Biochem Pharmacol 2016
135
8

Inhibitors of bromodomain and extra-terminal proteins for treating multiple human diseases.
Ewelina Kulikowski, Brooke D Rakai, Norman C W Wong. Med Res Rev 2021
39
8

Identification of nuclear hormone receptor pathways causing insulin resistance by transcriptional and epigenomic analysis.
Sona Kang, Linus T Tsai, Yiming Zhou, Adam Evertts, Su Xu, Michael J Griffin, Robbyn Issner, Holly J Whitton, Benjamin A Garcia, Charles B Epstein,[...]. Nat Cell Biol 2015
49
8


A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.
David E Gordon, Gwendolyn M Jang, Mehdi Bouhaddou, Jiewei Xu, Kirsten Obernier, Kris M White, Matthew J O'Meara, Veronica V Rezelj, Jeffrey Z Guo, Danielle L Swaney,[...]. Nature 2020
8

RING3 kinase transactivates promoters of cell cycle regulatory genes through E2F.
G V Denis, C Vaziri, N Guo, D V Faller. Cell Growth Differ 2000
130
8

Efferocytosis in atherosclerotic lesions: Malfunctioning regulatory pathways and control mechanisms.
Amir Tajbakhsh, Mehdi Rezaee, Petri T Kovanen, Amirhossein Sahebkar. Pharmacol Ther 2018
57
8


Targeting epigenetic readers in cancer.
Mark A Dawson, Tony Kouzarides, Brian J P Huntly. N Engl J Med 2012
274
8

RNA polymerase II elongation control.
Qiang Zhou, Tiandao Li, David H Price. Annu Rev Biochem 2012
400
8

Targeting bromodomain and extraterminal proteins in breast cancer.
Jennifer M Sahni, Ruth A Keri. Pharmacol Res 2018
26
8

AZD5153: A Novel Bivalent BET Bromodomain Inhibitor Highly Active against Hematologic Malignancies.
Garrett W Rhyasen, Maureen M Hattersley, Yi Yao, Austin Dulak, Wenxian Wang, Philip Petteruti, Ian L Dale, Scott Boiko, Tony Cheung, Jingwen Zhang,[...]. Mol Cancer Ther 2016
94
8

Apabetalone lowers serum alkaline phosphatase and improves cardiovascular risk in patients with cardiovascular disease.
Mathias Haarhaus, Kausik K Ray, Stephen J Nicholls, Gregory G Schwartz, Ewelina Kulikowski, Jan O Johansson, Michael Sweeney, Christopher Halliday, Kenneth Lebioda, Norman Wong,[...]. Atherosclerosis 2019
20
8

BET protein proteolysis targeting chimera (PROTAC) exerts potent lethal activity against mantle cell lymphoma cells.
B Sun, W Fiskus, Y Qian, K Rajapakshe, K Raina, K G Coleman, A P Crew, A Shen, D T Saenz, C P Mill,[...]. Leukemia 2018
92
8

MYC, a downstream target of BRD-NUT, is necessary and sufficient for the blockade of differentiation in NUT midline carcinoma.
Adlai R Grayson, Erica M Walsh, Michael J Cameron, Jernej Godec, Todd Ashworth, Jessica M Ambrose, Alexandra B Aserlind, Hongfang Wang, Gerard Evan, Michael J Kluk,[...]. Oncogene 2014
115
8

E mu-BRD2 transgenic mice develop B-cell lymphoma and leukemia.
Rebecca J Greenwald, Joseph R Tumang, Anupama Sinha, Nicolas Currier, Robert D Cardiff, Thomas L Rothstein, Douglas V Faller, Gerald V Denis. Blood 2004
88
8

Control of inducible gene expression by signal-dependent transcriptional elongation.
Diana C Hargreaves, Tiffany Horng, Ruslan Medzhitov. Cell 2009
482
8

First-in-Human Study of Mivebresib (ABBV-075), an Oral Pan-Inhibitor of Bromodomain and Extra Terminal Proteins, in Patients with Relapsed/Refractory Solid Tumors.
Sarina A Piha-Paul, Jasgit C Sachdev, Minal Barve, Patricia LoRusso, Russell Szmulewitz, Sapna Pradyuman Patel, Primo N Lara, Xiaotian Chen, Beibei Hu, Kevin J Freise,[...]. Clin Cancer Res 2019
76
8

Histone Deacetylases Positively Regulate Transcription through the Elongation Machinery.
Celeste B Greer, Yoshiaki Tanaka, Yoon Jung Kim, Peng Xie, Michael Q Zhang, In-Hyun Park, Tae Hoon Kim. Cell Rep 2015
99
8


BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism.
Daniela Boehm, Vincenzo Calvanese, Roy D Dar, Sifei Xing, Sebastian Schroeder, Laura Martins, Katherine Aull, Pao-Chen Li, Vicente Planelles, James E Bradner,[...]. Cell Cycle 2013
167
8

Epigenetic targeting of bromodomain protein BRD4 counteracts cancer cachexia and prolongs survival.
Marco Segatto, Raffaella Fittipaldi, Fabrizio Pin, Roberta Sartori, Kyung Dae Ko, Hossein Zare, Claudio Fenizia, Gianpietro Zanchettin, Elisa Sefora Pierobon, Shinji Hatakeyama,[...]. Nat Commun 2017
58
8

The chromatin-targeting protein Brd2 is required for neural tube closure and embryogenesis.
Aron Gyuris, Diana J Donovan, Kimberly A Seymour, Lindsay A Lovasco, Nathaniel R Smilowitz, Anthony L P Halperin, Jan E Klysik, Richard N Freiman. Biochim Biophys Acta 2009
66
8

Mechanisms of foam cell formation in atherosclerosis.
Dimitry A Chistiakov, Alexandra A Melnichenko, Veronika A Myasoedova, Andrey V Grechko, Alexander N Orekhov. J Mol Med (Berl) 2017
252
8

BRD4 regulates adiponectin gene induction by recruiting the P-TEFb complex to the transcribed region of the gene.
Naoko Sakurai, Yuko Inamochi, Takuya Inoue, Natsuyo Hariya, Musashi Kawamura, Masami Yamada, Anup Dey, Akira Nishiyama, Takeo Kubota, Keiko Ozato,[...]. Sci Rep 2017
18
8

Selective inhibition of the BD2 bromodomain of BET proteins in prostate cancer.
Emily J Faivre, Keith F McDaniel, Daniel H Albert, Srinivasa R Mantena, Joshua P Plotnik, Denise Wilcox, Lu Zhang, Mai H Bui, George S Sheppard, Le Wang,[...]. Nature 2020
158
8

The BRD3 ET domain recognizes a short peptide motif through a mechanism that is conserved across chromatin remodelers and transcriptional regulators.
Dorothy C C Wai, Taylor N Szyszka, Amy E Campbell, Cherry Kwong, Lorna E Wilkinson-White, Ana P G Silva, Jason K K Low, Ann H Kwan, Roland Gamsjaeger, James D Chalmers,[...]. J Biol Chem 2018
21
8

Bromodomain Drug Discovery - the Past, the Present, and the Future.
Mehrosh Pervaiz, Pankaj Mishra, Stefan Günther. Chem Rec 2018
58
8


Translating the histone code.
T Jenuwein, C D Allis. Science 2001
8

An iridium(iii)-based irreversible protein-protein interaction inhibitor of BRD4 as a potent anticancer agent.
Hai-Jing Zhong, Lihua Lu, Ka-Ho Leung, Catherine C L Wong, Chao Peng, Siu-Cheong Yan, Dik-Lung Ma, Zongwei Cai, Hui-Min David Wang, Chung-Hang Leung. Chem Sci 2015
78
8

Acute TNF-induced repression of cell identity genes is mediated by NFκB-directed redistribution of cofactors from super-enhancers.
Søren Fisker Schmidt, Bjørk Ditlev Larsen, Anne Loft, Ronni Nielsen, Jesper Grud Skat Madsen, Susanne Mandrup. Genome Res 2015
45
8

Discovery of epigenetic regulator I-BET762: lead optimization to afford a clinical candidate inhibitor of the BET bromodomains.
Olivier Mirguet, Romain Gosmini, Jérôme Toum, Catherine A Clément, Mélanie Barnathan, Jean-Marie Brusq, Jacqueline E Mordaunt, Richard M Grimes, Miriam Crowe, Olivier Pineau,[...]. J Med Chem 2013
207
8

Identification of transcription complexes that contain the double bromodomain protein Brd2 and chromatin remodeling machines.
Gerald V Denis, Mark E McComb, Douglas V Faller, Anupama Sinha, Paul B Romesser, Catherine E Costello. J Proteome Res 2006
105
8

Discovery of novel small molecule induced selective degradation of the bromodomain and extra-terminal (BET) bromodomain protein BRD4 and BRD2 with cellular potencies.
Fei Jiang, Qingyun Wei, Huili Li, Hongmei Li, Yong Cui, Yu Ma, Haifang Chen, Peng Cao, Tao Lu, Yadong Chen. Bioorg Med Chem 2020
14
8

Downregulation of the Complement Cascade In Vitro, in Mice and in Patients with Cardiovascular Disease by the BET Protein Inhibitor Apabetalone (RVX-208).
Sylwia Wasiak, Dean Gilham, Laura M Tsujikawa, Christopher Halliday, Cyrus Calosing, Ravi Jahagirdar, Jan Johansson, Michael Sweeney, Norman C Wong, Ewelina Kulikowski. J Cardiovasc Transl Res 2017
30
8


First-in-human phase I study of the bromodomain and extraterminal motif inhibitor BAY 1238097: emerging pharmacokinetic/pharmacodynamic relationship and early termination due to unexpected toxicity.
Sophie Postel-Vinay, Karin Herbschleb, Christophe Massard, Victoria Woodcock, Jean-Charles Soria, Annette O Walter, Flavio Ewerton, Martine Poelman, Neil Benson, Matthias Ocker,[...]. Eur J Cancer 2019
47
8

BETP degradation simultaneously targets acute myelogenous leukemia stem cells and the microenvironment.
Sujan Piya, Hong Mu, Seemana Bhattacharya, Philip L Lorenzi, R Eric Davis, Teresa McQueen, Vivian Ruvolo, Natalia Baran, Zhiqiang Wang, Yimin Qian,[...]. J Clin Invest 2019
32
8

Selective inhibition of BET proteins reduces pancreatic damage and systemic inflammation in bile acid- and fatty acid ethyl ester- but not caerulein-induced acute pancreatitis.
Wei Huang, Andrea C Haynes, Rajarshi Mukherjee, Li Wen, Diane Latawiec, Alexei V Tepikin, David N Criddle, Rab K Prinjha, Nicholas Smithers, Robert Sutton. Pancreatology 2017
10
10

Signaling effectors underlying pathologic growth and remodeling of the heart.
Jop H van Berlo, Marjorie Maillet, Jeffery D Molkentin. J Clin Invest 2013
305
8

Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4.
Zhiyuan Yang, Jasper H N Yik, Ruichuan Chen, Nanhai He, Moon Kyoo Jang, Keiko Ozato, Qiang Zhou. Mol Cell 2005
796
8

Structural features and inhibitors of bromodomains.
Jamel Meslamani, Steven G Smith, Roberto Sanchez, Ming-Ming Zhou. Drug Discov Today Technol 2016
13
8

Role of BET Inhibitors in Triple Negative Breast Cancers.
Durga Khandekar, Venkataswarup Tiriveedhi. Cancers (Basel) 2020
10
10

Discovery, structural insight, and bioactivities of BY27 as a selective inhibitor of the second bromodomains of BET proteins.
Deheng Chen, Tian Lu, Ziqin Yan, Wenchao Lu, Feilong Zhou, Xilin Lyu, Biling Xu, Hualiang Jiang, Kaixian Chen, Cheng Luo,[...]. Eur J Med Chem 2019
18
8

BET protein Brd4 activates transcription in neurons and BET inhibitor Jq1 blocks memory in mice.
Erica Korb, Margo Herre, Ilana Zucker-Scharff, Robert B Darnell, C David Allis. Nat Neurosci 2015
148
8

The double bromodomain protein Brd4 binds to acetylated chromatin during interphase and mitosis.
Anup Dey, Farideh Chitsaz, Asim Abbasi, Tom Misteli, Keiko Ozato. Proc Natl Acad Sci U S A 2003
468
8

Role of histone H3 lysine 9 methylation in epigenetic control of heterochromatin assembly.
J Nakayama , J C Rice, B D Strahl, C D Allis, S I Grewal. Science 2001
8

Cardiac plasticity.
Joseph A Hill, Eric N Olson. N Engl J Med 2008
804
8

Benefit of Apabetalone on Plasma Proteins in Renal Disease.
Sylwia Wasiak, Laura M Tsujikawa, Christopher Halliday, Stephanie C Stotz, Dean Gilham, Ravi Jahagirdar, Kamyar Kalantar-Zadeh, Richard Robson, Michael Sweeney, Jan O Johansson,[...]. Kidney Int Rep 2017
23
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.